1. Home
  2. SGHT vs BGT Comparison

SGHT vs BGT Comparison

Compare SGHT & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$4.00

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$10.58

Market Cap

317.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
BGT
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
187.4M
317.3M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
SGHT
BGT
Price
$4.00
$10.58
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
380.0K
122.6K
Earning Date
03-04-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
28.16
N/A
EPS
N/A
N/A
Revenue
$77,363,000.00
N/A
Revenue This Year
$11.81
N/A
Revenue Next Year
$10.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.03
$10.21
52 Week High
$9.24
$12.76

Technical Indicators

Market Signals
Indicator
SGHT
BGT
Relative Strength Index (RSI) 42.49 26.17
Support Level $3.99 N/A
Resistance Level $4.33 $11.44
Average True Range (ATR) 0.22 0.12
MACD 0.09 0.01
Stochastic Oscillator 69.19 0.00

Price Performance

Historical Comparison
SGHT
BGT

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

Share on Social Networks: